Amanat, M.; Nemeth, C.L.; Fine, A.S.; Leung, D.G.; Fatemi, A.
Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology. Pharmaceutics 2022, 14, 2389.
https://doi.org/10.3390/pharmaceutics14112389
AMA Style
Amanat M, Nemeth CL, Fine AS, Leung DG, Fatemi A.
Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology. Pharmaceutics. 2022; 14(11):2389.
https://doi.org/10.3390/pharmaceutics14112389
Chicago/Turabian Style
Amanat, Man, Christina L. Nemeth, Amena Smith Fine, Doris G. Leung, and Ali Fatemi.
2022. "Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology" Pharmaceutics 14, no. 11: 2389.
https://doi.org/10.3390/pharmaceutics14112389
APA Style
Amanat, M., Nemeth, C. L., Fine, A. S., Leung, D. G., & Fatemi, A.
(2022). Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology. Pharmaceutics, 14(11), 2389.
https://doi.org/10.3390/pharmaceutics14112389